Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Shanghai Sinobioway Sunterra Biotechnology focuses on cutting-edge biotechnology, specifically in the field of adoptive cellular therapies. It was formed by Sinobioway Group, Sunterra Capital, and F1 Oncology for the express purpose of developing novel CAB-CAR-T therapies for solid tumor malignancies in China. SSSB&s;s GMP cell processing facilities in Shanghai have been developed to support clinical research through key academic collaborations.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2018 | Exuma Biotech | Venture Round | 10M |
1/2018 | Exuma Biotech | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|